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Abstract The growing interest of the pharmaceutical industry in Near Infrared-Chemical Imaging
(NIR-CI) is a result of its high usefulness for quality control analyses of drugs throughout their
production process (particularly of its non-destructive nature and expeditious data acquisition).
In this work, the concentration and distribution of the major and minor components of
pharmaceutical tablets are determined and the spatial distribution from the internal and external
sides has been obtained. In addition, the same NIR-CI allowed the coating thickness and its surface
distribution to be quantiﬁed. Images were processed to extract the target data and calibration
models constructed using the Partial Least Squares (PLS) algorithms. The concentrations of
Active Pharmaceutical Ingredient (API) and excipients obtained for uncoated cores were
essentially identical to the nominal values of the pharmaceutical formulation. But the predictive
ability of the calibration models applied to the coated tablets decreased as the coating thickness
increased.
& 2011 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.
1. Introduction
Near Infrared-Chemical Imaging (NIR-CI) is a technique
based on conventional NIR spectroscopy with the added
advantage that it affords recording of a large amount of both
spectral and spatial information in a single image. While the
conventional NIR technique only provides the average spec-
trum for the surface of each sample, NIR-CI gives one
spectrum per pixel in each acquired image and hence much
more information about the whole sample surface [1]. The
easiness to obtain this information through with NIR-CI has
aroused interest in NIR-CI in many ﬁelds of study. This is
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Table 1 Composition (% w/w) of API and the two major
excipients at different coating levels.
Coating level Sample composition (% w/w)
API E #1 E #2
0x 35.0 40.0 20.0
0.5x 34.4 39.3 19.7
1x 33.9 38.8 19.4
2x 33.0 37.7 18.7
3x 32.0 36.6 18.3
0x means uncoated core and 1x means nominal standard
coating.
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products, which is made easy by NIR-CI by virtue of its
ability to acquire a vast amount of information in an
expeditious manner, all without altering the sample. The
increasing interest aroused by NIR-CI in the pharmaceutical
ﬁeld is evident from the variety of studies based on this
technique reported in recent years. Such studies include the
homogeneity of powder samples [2], particle size determina-
tions [3], product composition [4], the determination of the
concentrations and distribution of components in solid tablets
[5] and content uniformity [6], among others. Also, the many
uses of NIR-CI in the pharmaceutical industry have been the
subject of two interesting reviews [1,7].
Film coatings on commercial tablets have been the subject
of some study [8,9], but not so much as pharmaceutical
components despite their signiﬁcance. The coating ﬁlm applied
to a drug tablet is primarily intended to improve its esthetics
and function. Thus, the coating allows the unpleasant taste of
some APIs to be masked and facilitates swallowing of tablets,
in addition to preserving their integrity and giving them a
uniform appearance. Some coatings, however, are intended to
facilitate the controlled or enteric release of the dosage form of
a drug [10]. In any case, the exact function of a coating
depends largely on its thickness and distribution on the tablet
surface. In fact, too thin or too thick a coating can alter the
effectiveness of a tablet by making the core more vulnerable to
external factors or diminishing the API release rate. Simply
measuring the average thickness of the lacquer ﬁlm on a tablet
is inadequate to ensure that the tablet will meet the speciﬁca-
tions; rather, this requires obtaining more information about
the way the coating is distributed throughout the tablet
surface. The capabilities of the NIR-CI technique in this
respect make it a suitable choice for quality control in tablet
production processes.
However, the vast amount of information contained in a
hyperspectral image requires the use of an effective procedure
to extract it. In fact, hyperspectral data form a three-way cube
that must be unfolded and processed with appropriate two-
way multivariate algorithms in order to extract the target
information.
In those cases where some components of a pharmaceutical
are unknown or a spectrum unavailable, algorithms requiring
no calibration set are especially useful; such algorithms include
Multivariate Curve Resolution-Alternating Least Squares
(MCR-ALS) [11] and its augmented form [12]. However, the
process involved in extracting information from chemical
images can be slow and cumbersome. One alternative choice
in wide use for the quantitative analysis of CI data is Partial
Least Squares (PLS) [13]. The Isys software included with the
NIR-CI instrument allows the easy application of PLS for a
rapid and accurate determination of components distribution
in a sample. This algorithm requires a series of data distrib-
uted over a wide enough range of speciﬁc values of the target
property to allow the construction of a suitable calibration
model for the samples to be analyzed. Each pixel of the image
is assigned to a response matrix based on the similarity of its
spectra with those for the pure components [14].
In this work we intend to evaluate the distribution of the
components in a tablet and quantify the thickness and surface
distribution of the ﬁlm coating during the development of a
new pharmaceutical formulation. Individual calibration mod-
els for the components were used to obtain their distributionmap and a calibration model derived from the NIR-CI
hyperspectral image was used to establish the distribution
map for the coating ﬁlm.2. Materials and methods
2.1. Samples
We studied three different types of samples, namely: (a) cores
(uncoated tablets), (b) tablets with a coating of variable
thickness and (c) tablets with the standard coating. The coated
tablets (b) included samples with ﬁlm thicknesses between 0x
and 3x, where x is considered the standard coating thickness
of tablets (c).
We consider the coating process is constant and reprodu-
cible along time. The standard time encompasses a coating
thickness namely x. The double or triple of this standard time
are named 2x and 3x. The reference coating thickness has
been calculated measuring the approximate tablet surface
(1.92 cm2), the tablet weight difference before and after coat-
ing (from 290 mg to 317 mg) and the real density of the
coating polymer (1.19 g/cm3). This measurement was 39.4 mm
of coating thickness for a x standard coating time, 21.9 mm for
0.5x, 78.8 mm for 2x and 118.2 mm for 3x. The estimated
measurement for a standard x coating time (39.4 mm) was
quite similar to the coating thickness obtained by scanning
electron microscopy (SEM, 40 mm). However, we could not
compare the calculated thickness and the SEM results for all
the coating levels. In this work, all the coating thickness results
are referred to the x standard coating time instead of the
microns measurements, in order to simplify and better under-
stand the conclusions.
The uncoated cores had the same API and excipient
composition, namely: 35% API and 65% excipients. The
excipient mixture contained 40% of excipient #1, 20% of
excipient #2, 2% of excipient #3, 1.5% of excipient #4 and
1.5% of excipient #5. The API and the two major excipients in
combination accounted for 95% of the tablet content. The
presence of the lacquer in the coated tablets reduced the
proportions of API and excipients to an extent dependent on
the coating thickness. Table 1 shows the resulting changes in
the major components.
The samples in groups a and b were used to determine the
concentrations of the tablet components (API and excipients).
A. Palou et al.92Those in group b were used as calibration and validation sets
for the PLS models employed to characterize the coating
thickness, which were subsequently applied to the group c
tablets.
2.2. Instrumentation
Images were acquired with a SyNIRgyTM Chemical Imaging
System hyperspectral camera from Malvern Instruments
(Malvern, UK). The camera was equipped with an InSb
detector with a focal plane array of 320 256 pixels and
controlled via the software Pixyss 1.1., also from Malvern.
Samples were placed on the plate and lighted with halogen
lamps arranged at appropriate angles around the plate, the
lens distance being adjusted according to the object size. The
images obtained under the selected conditions had a resolu-
tion of 40 mm (each pixel covered an area of 40 mm 40 mm).
The acquisition time for a reﬂectance image spanning the
wavelength range 1200–2400 nm was about 3 min. Prior to
acquisition of the image for the sample (S), the camera was
used to record one for the background (B, a reference ceramic
plate of 99% reﬂectance) and another for a dark reference
(D, a mirror). The image for the sample, S, was converted
into reﬂectance data, R, using the equation R¼(SD)/(BD).
This calculation was done at every pixel in each image.
The data thus obtained were then converted into absorbance
units.
Each core was used to record 6 different images: 4 of each
outer side (A–D) and 2 of the interior sides (E–F) which were
establish by breaking the tablets as shown in Fig. 1a. The
analysis of the interior sides was performed to check the
homogeneity of the samples. The analytical method does not
require breaking the samples as it is considered nondestruc-
tive. The tablets group c (standard x coated) were used to
study the four outer sides only, which were designated
identically with those of the cores (A–D). On the other hand,
each of the two tablets in sample group b was used to record
the images, one from each of two opposite outer sides. Fig. 1b
shows the image of two tablets with identical characteristics
(coating thickness). The images were not studied in their
entirety, but rather in selected rectangular areas on the inner
sides of each tablet in order to avoid image distortions caused
by light impinging on tablet edges.Figure 1 Schema of the tablet sides analyzed by hyperspectral
imaging: (a) cores and production tablets and (b) tablets with
different coating times. The selected area for analysis of samples
(B) is highlighted with dark gray color.The images for the pure compounds were obtained by
placing an adequate powder amount of each in a glass cell and
gently pressing its surface prior to recording.2.3. Data processing
The data in a hyperspectral image are arranged in a three-way
data cube X(MN l) two dimensions in which (MN)
hold spatial information while the third (l) contains spectral
information.
Prior to application of any spectral treatment or algorithm
to extract the required information, the data cube must be
unfolded into a two-dimensional matrix since most existing
treatments and algorithms have been developed for two-way
data. The data matrices thus obtained here from each image
were processed with the Standard Normal Variate (SNV)
algorithm. All spectral quantitative treatments used were
applied using the software Isys 5.0, from Malvern, with
routines developed in MATLAB code (MATLAB v 7.0, The
MathWorks, Natick, MA). This software only required the
previous acquisition of the pure spectrum for each component
to be determined [15]. The pure spectra were used to construct
a library and then quantify the concentration of each compo-
nent. The calibration model was completed by selecting an
appropriate thresholds and number of factors. Using an
increased number of factors increased the variance Y
explained by the model, but also the risk of overﬁtting; a
compromise was therefore needed for an optimal choice. The
threshold used, which allows one to adjust the limits for
discrimination between classes, is a function of the similarity
between the spectrum for each pure component to be quanti-
ﬁed and those for the other components in addition to the
number of factors previously selected. Application of the
resulting model weighted the spectral data in image based
on a 0 to 1 scale. This scale corresponds from 0 to 100%
concentration of each component at every pixel of the image.
The result was delivered as a concentration map and mean
concentration for each component present in the library. This
algorithm has been applied for the calculation of the calibra-
tion models for every component of the formulation. The
information provided by Malvern about the PLS algorithm
included in the Isys software is minimum. However we
understand this algorithm is a variation of the discriminant
PLS, that allows to individually quantify every component of
the sample only using its pure spectrum without the need of
the other spectra (it does not act as the classical least squares
algorithm that strictly needs all the pure spectra components
of a formulation).
The thickness and distribution of the coating were quanti-
ﬁed using PLS calibration models calculated with the software
The Unscrambler v. 9.8 from CAMO (Trondheim, Norway).
The PLS regression algorithm [15] uses as X-spectral data
the mean spectrum of the selected area of every image. The
Y-variable corresponded to the thickness reference value
(Table 1). The PLS model thus constructed was validated by
cross-validation applying jack-kniﬁng algorithm in order to
identify the wavelength range most strongly correlated with
such property. Then, the optimum number of factors was
selected under the above-described criteria. The analysis of a
NIR-CI image by this PLS model was performed after the
unfolding of the three-way data cube into a two-way data set.
Determination of drug, excipients and coating distribution using NIR-CI 93The distribution map of tablet coating was performed refold-
ing the two-way data set of PLS prediction results into a three-
way data cube.Figure 3 NIR spectra of an uncoated core and a coated tablet.
The NIR spectra have been obtained averaging the spectra of each
pixel of an area of the hyperspectral image.
Table 3 API and excipients concentration (% w/w) from
different sides of the same core.
Core side Core composition (% w/w)
API E #1 E #2 E #3 E #4 E #5 Sum3. Results and discussion
The goal of this study is the application of NIR-CI to better
understand the API and excipients distribution of a novel
pharmaceutical formulation and eventually feedback this
information to the development stages. Quantitative methods
for the determination of tablet components and their distribu-
tion in the core and its coating from NIR-CI image have been
developed. Fig. 2 shows the spectra for the different pure
components of the studied pharmaceutical (viz. the API and 5
excipients). The spectra exhibited marked differences that are
conﬁrmed by the pairwise correlation coefﬁcients shown in
Table 2. The high spectral similarity of the excipients #2
and #4 (correlation coefﬁcient of 0.984) is one of the main
difﬁculties during the development of the calibration models
of these two components. The coating ﬁlm does not provide a
signiﬁcant absorption compared to the cores spectra. Fig. 3
compares the average spectra of selected area of an uncoated
core and a coated tablet. The spectral differences were
minimal as a result of the subtle contribution of the coatingFigure 2 NIR spectra of pure API and excipients. Each spectrum
has been baseline shift to avoid overlapping. The NIR spectra
have been obtained averaging the spectra of each pixel of an area
of the hyperspectral image.
Table 2 Correlation coeﬁcient between the average NIR
spectra of the pure tablet components (API and excipients).
Correlation coefﬁcients
API E #1 E #2 E #3 E #4 E #5
API 1.000
E #1 0.810 1.000
E #2 0.621 0.601 1.000
E #3 0.693 0.603 0.849 1.000
E #4 0.640 0.588 0.984 0.903 1.000
E #5 0.823 0.693 0.669 0.847 0.740 1.000
The NIR spectra have been obtained averaging the spectra of
each pixel of the hyperspectral image.
Side A 35.51 38.93 20.15 1.97 1.48 1.47 99.51
Side B 35.45 39.48 21.12 1.98 1.48 1.51 101.00
Side C 37.11 38.45 19.69 1.99 1.53 1.53 100.30
Side D 37.45 40.38 20.14 1.95 1.53 1.51 102.96
Side E 31.61 44.16 18.62 1.95 1.48 1.51 99.38
Side F 31.47 43.38 19.31 1.97 1.55 1.53 99.21
Mean 34.78 40.79 19.84 1.97 1.51 1.51 100.40
St. dev. 2.62 2.41 0.85 0.02 0.03 0.02 5.95
Results calculated with the PLS calibration model. Sides A to F
according to Fig. 1.layer and the lacquer produces a slightly increased baseline of
the average spectrum.3.1. Quantitation of the API and excipients
We constructed a model to determine the concentration of the
active principle and ﬁve excipients present in the cores by
calculating a PLS calibration model for each analyte. The
models were constructed by compiling a library containing the
spectra for the pure components to be quantiﬁed and applying
the Isys 5.0 algorithm with a variable number of factors from
3 to 8 depending on the particular analyte. The number of
PLS factors needed for each calibration model increases as the
concentration of the analyte decreases. The concentrations of
the six components thus obtained for each core side are listed
in Table 3. The model-predicted concentrations for each core
side were very similar to the nominal values for the API and
the major and minor excipients. The greatest standard devia-
tion corresponds to the two major components (API and
Excipient #1) that indicate an incomplete homogenous dis-
tribution. However, the standard deviation for the minor
excipients is low, that is a conﬁrmation of their homogeneous
distribution. Worth special note is the fact that the combined
A. Palou et al.94proportions of the components on each side were close to
100% in all cases, which suggest that the calibration models
used provide accurate predictions.
However, there are slight differences in composition between
sides for the three major components. Thus, the concentrations
of the three major components (API and excipients #1 and #2)
on the inner sides (E and F) in the cores departed from both the
nominal values and the values for the other sides. These
differences can be ascribed to the increased roughness of the
cut surface, which may inﬂuence the reﬂectance of the acquired
images and consequently it can also inﬂuence the calculated
concentrations.
Fig. 4 shows the concentration maps for the components on
one of the outer sides of a core as obtained with the Isys 5.0
models. The distributions of excipient #2 and the API were
very similar, with coinciding areas of increased concentrations.
On the other hand, the high-concentration areas for excipient
#1 were complementary with those for the API. This distribu-
tion pattern can be ascribed to the fact that the API and
excipient #2 are mixed together before the other componentsFigure 4 Concentration distribution maps and histograms for API an
is shown the nominal concentration (% w/w) of each component.are added. By contrast, the minor excipients were uniformly
distributed across the images. The API and excipient distribu-
tions observed on the other sides and cores exhibited no
signiﬁcant differences from the previous side and exhibited
identical patterns.
Fig. 4 also includes the histogram for each core component.
The histograms for the minor excipients exhibited a narrow
distribution of concentration values. The histograms for the
API and excipient #2 were very similarly shaped, with tails on
the left. By contrast, the tails in the histogram for excipient #1
were on the right, which suggests an incomplete homogenous
distribution of this excipient with the blend of API and
excipient #2. In any case, the distributions cannot be con-
sidered as normal shaped.3.2. Quantitation of coated tablets
The API and excipients were also determined in tablets coated
with a lacquer ﬁlm of variable thickness. We used PLS modelsd excipients for side A of a core calculated by PLS. In parenthesis
Table 4 Concentrations (% w/w) of API and two major
excipients in tablets with different coating thickness.
Coating level Tablet side Tablet components (%w/w)
API E #1 E #2
0x A 35.25 40.74 20.20
B 35.67 39.46 21.34
0.5x A 35.85 40.30 19.67
B 35.31 40.27 20.36
1x A 34.56 40.80 20.79
B 35.20 40.18 21.64
2x A 33.15 39.15 17.95
B 32.95 42.40 15.31
3x A 30.85 38.51 12.65
B 29.65 39.78 14.03
Results obtained with the PLS calibration model.
Figure 5 NIR spectra of tablets coated at different levels. The
level 1x corresponds to the coating thickness of production
tablets.
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on the particular analyte and coating thickness. Table 4 shows
the results obtained for two sides (A and B) of the same tablet
but coated to a different thickness with a lacquer ﬁlm. The
results are the averages for two tablets coated with an identical
coating time and recorded in a single image. The values for the
minor components have been omitted because they exhibited
high deviations (50–30%) from the nominal values. The calcu-
lated concentrations for the three major components are close to
their respective nominal values (Table 1) and decrease gradually
with increasing coating thickness. Obviously, deviations from the
nominal values are the highest in the tablets with the thickest
coatings (levels 2x and 3x); this is particularly so for excipient #2,
which has the low concentration.
Based on the previous results, the deviations in the calculated
concentrations are mainly the result of the lacquer coating, which
affects the determination of the concentrations of the major
components and, especially, the minor ones. This fact can be
related with a higher absorption of the incident radiation or a
certain reﬂective scattering of the coating that reduces the signal
of the core components.3.3. Quantitation of the thickness of coating
The thickness of the coating is an important variable inasmuch
as it can inﬂuence the rate of dissolution of a tablet and also
the quality of components quantitation. In this work, tablet
thickness was determined using a PLS model constructed from
the average spectrum for each tablet side as a function of
coating time. Fig. 5 shows the mean spectra for each coating
level (from 0x to 3x). The band between 1800 and 2000 nm
increased their intensity with the coating time. Also there are
other bands along the whole range that showed differences
according to the coating time.
A total of 10 images of tablets coated to a variable thickness
(two tablets per image) were obtained. The spectra of the
selected area of image were averaged to obtain 4 spectra per
each thickness (2 tablets per image and 2 sides per tablet).
Three of the 20 spectra thus obtained were discarded asoutliers, 12 were used to construct the calibration set and 5
to validate it. Each average spectrum in the calibration set was
assigned a time of coating of 0x, 0.5x, 1x, 2x or 3x. These
coating thickness were determined from the increase in weight
of the tablets upon coating. Different spectral pretreatments
were tested during the development of the PLS calibration
models (derivation, Savitzky–Golay, SNV) and also different
wavelength ranges were selected in order to ensure optimal
ﬁtting to the validation set. The best results were obtained by
processing data with the SNV algorithm and using the entire
spectral range. The calibration model calculated using the
spectral range where the coating presented a signiﬁcant
absorption did not improve the predictive ability compared
to the model without this range. Under these conditions, a
model with a single factor accounted for 99.3% of the total
variance. Such a PLS model, which is described in detail in
Table 5, was adopted for application to tablets c.
The application of the calibration model to a NIR-CI
allowed to quantify the mean coating thickness and its
distribution over the surface. Fig. 6 shows the concentration
maps for the tablet coating on the four outer sides of a tablet c
(Table 1), which were processed with the previous PLS model.
A comparison of the four concentration maps reveals that the
coating material is not homogenously distributed on all sides.
There were some points where the predicted concentration was
higher than those on the remainder of the surface. This may
have resulted from the formation of lacquer aggregates during
the coating process and indicate an irregular spraying inside
the coating container drum. Fig. 6 additionally shows the
histograms for easier analysis of the heterogeneous coating
distribution.
Table 6 shows the average coating values for each of the
four studied sides on two tablets c calculated with the above-
described PLS model. Both tablet 1 and 2 exhibited differences
of up to 10% (0.1x) in coating content from the nominal value
between sides; however, the average for the four tablet sides
was very similar to the nominal value in all samples.4. Conclusions
In this work, we assessed the potential for the NIR-CI technique
for determining the composition of coated and uncoated drug
Table 5 Figures of merit for the quantiﬁcation of coating thickness obtained with the PLS calibration model.
PLS calibration model features
Number of calibration
samples included
Spectral
range (nm)
Spectral
pretreatment
Number of PLS
factors
Y-variance
(%)
Number of
validation samples
RMSEPa RSEP
(%)a
12 1200–2400 SNV 1 99.31 5 14.04 8.32
RSEP: Relative Standard Error of Prediction.
aRMSEP: Root Mean Square Error of Prediction.
Figure 6 Tablet coating distribution maps and histrograms for the four sides of one production tablet calculated by the PLS calibration
model. The percentage of whole tablet image that represents the shown area is provided by the valued between parenthesis.
A. Palou et al.96tablets, and the distribution of their components. We found the
PLS algorithm to be effective towards extracting quality quanti-
tative information from hyperspectral images without the
need for calibration against reference values, and also towards
establishing the distribution of tablet components. Conventional
processing of the spectral data contained in an image allows oneto determine the thickness of the coating layer with a view
to predicting some pharmaceutical properties of the tablet.
The expeditiousness with which it allows tablets to be analyzed,
and the accuracy of its predictions, make the NIR-CI technique
a highly suitable choice for the determination of the quantita-
tive composition of pharmaceutical tablets, and for assessing
Table 6 Coating thickness (as a function of x) in two
production tablets obtained applying the described PLS
calibration model.
Tablet side Coating thickness (as a function of x)
Tablet 1 Tablet 2
Side A 1.035 1.122
Side B 0.984 1.177
Side C 0.739 1.035
Side D 0.925 1.223
Mean (4 sides) 0.921 1.139
x¼nominal thickness (approximately 40 mm).
Determination of drug, excipients and coating distribution using NIR-CI 97uniformity in the distribution of its components and surface
coating. These advantages testify to the potential of NIR-CI for
use in at-line tests for the control of pharmaceutical production
processes.
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